Longer Time Interval from Neoadjuvant Chemoradiation to Surgery is Associated with Poor Survival for Patients Without Clinical Complete Response in Oesophageal Cancer

Background The optimal interval between neoadjuvant therapy and oesophagectomy for oesophageal cancer remains controversial. Methods Patients with locally advanced oesophageal squamous cell carcinoma (ESCC) who received neoadjuvant chemoradiotherapy followed by oesophagectomy between June 2017 and D...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2023-02, Vol.30 (2), p.886-896
Hauptverfasser:	Xiao, Xin, Cheng, Chao, Cheng, Liang, Shang, Qi-Xin, Yang, Yu-Shang, Zeng, Xiao-Xi, Hu, Yang, Chen, Long-Qi, Yuan, Yong
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemoradiotherapy Complications Esophageal cancer Esophageal Neoplasms Esophageal Squamous Cell Carcinoma - pathology Esophagus Humans Medicine Medicine & Public Health Neoadjuvant Therapy Neoplasm Staging Oncology Patients Postoperative Retrospective Studies Squamous cell carcinoma Surgery Surgical Oncology Thoracic Oncology Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!